The continuation patent covers more isoquinolinamine compounds as well as the pharmaceutical composition and method to produce an antitumor effect in several different kinds of cancer
The patent covers the process of culturing central nervous system cells and transplanting them into spinal cord tissue to treat neurodegenerative disorders, such as amytrophic lateral sclerosis
The patent covers a method to promote mucus clearance in those with pulmonary conditions that lead to excess mucus secretion or impaired mucus clearance present in diseases such as cystic fibrosis and chronic obstructive pulmonary disease
The patent covers its formulation of inhalation particles that are composed of drug nanoparticles agglomerated together...That patent covers methods of producing and self-renewing PDGF-responsive precursor cells in culture using PDGF and FGF-2
The patent covers methods used in the BACcel and also claims alternative methods that a competitor might otherwise use to circumvent the BACcel's specific design
The patent covers methods applied to both individual and patient populations...The patent covers a method for improving sexual function by activating serotonin or dopamine neurotransmission, or a combination of both
The patent covers a dual cell culture chamber connecting by a specialized membrane, which allows two different cell types to exchange soluble factors with each other without mixing the cells
The patent covers a method of treating patients with anogenital warts using a fusion protein comprised of a heat-shock protein from the Hsp60 family and an HPV E7 antigen
The patent covers the use of RPM in combination with various demineralized bone-matrix formulations, such as those based on the company's Accell technology
The patent covers small-molecule EZH2 inhibitor EPZ-6438 (E7438) for treating non-Hodgkin lymphomas...The patent covers Synthetic's drug candidate, Trimesta (oral estriol) in combination with Copaxone (glatiramer acetate injection, Teva Pharmaceutical Industries Ltd